NO20050571L - Nye ikke steroide anti-inflammatoriske substanser, sammensetninger og metoder for deres anvendelse - Google Patents

Nye ikke steroide anti-inflammatoriske substanser, sammensetninger og metoder for deres anvendelse

Info

Publication number: NO20050571L
Authority: NO; Norway
Prior art keywords: methods; macrolide; compositions; inflammatory; steroidal anti
Prior art date: 2002-07-08

Application number

NO20050571A

Other languages

English (en)

Norwegian (no)

Inventor

Mladen Mercep

Milan Mesic

Linda Tomaskovic

Stribor Markovic

Original Assignee

Pliva Istrazivacki Inst Doo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-08

Filing date

2005-02-02

Publication date

2005-03-31

2005-02-02 Application filed by Pliva Istrazivacki Inst Doo filed Critical Pliva Istrazivacki Inst Doo

2005-03-31 Publication of NO20050571L publication Critical patent/NO20050571L/no

Links

230000003637 steroidlike Effects 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
239000002260 anti-inflammatory agent Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000003814 drug Substances 0.000 abstract 3
239000003120 macrolide antibiotic agent Substances 0.000 abstract 3
229940079593 drug Drugs 0.000 abstract 2
238000004519 manufacturing process Methods 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000001754 anti-pyretic effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
210000004969 inflammatory cell Anatomy 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
125000005647 linker group Chemical group 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
150000003431 steroids Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pulmonology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Dermatology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Transplantation (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Communicable Diseases (AREA)

NO20050571A 2002-07-08 2005-02-02 Nye ikke steroide anti-inflammatoriske substanser, sammensetninger og metoder for deres anvendelse NO20050571L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39467102P	2002-07-08	2002-07-08
PCT/HR2003/000035 WO2004005309A2 (en)	2002-07-08	2003-07-07	Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use

Publications (1)

Publication Number	Publication Date
NO20050571L true NO20050571L (no)	2005-03-31

Family

ID=30115753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20050571A NO20050571L (no)	2002-07-08	2005-02-02	Nye ikke steroide anti-inflammatoriske substanser, sammensetninger og metoder for deres anvendelse

Country Status (15)

Country	Link
US (1)	US7109176B2 (sr)
EP (1)	EP1521763A2 (sr)
JP (2)	JP2005536488A (sr)
CN (1)	CN100417659C (sr)
AR (1)	AR040951A1 (sr)
AU (1)	AU2003255849A1 (sr)
BR (1)	BR0312584A (sr)
CA (1)	CA2489398A1 (sr)
IS (1)	IS7686A (sr)
NO (1)	NO20050571L (sr)
NZ (1)	NZ537716A (sr)
PL (1)	PL374646A1 (sr)
RS (1)	RS20050007A (sr)
RU (1)	RU2342398C2 (sr)
WO (1)	WO2004005309A2 (sr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1483579A4 (en) *	2002-02-15	2006-07-12	Merckle Gmbh	CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THEIR MANUFACTURE AND USE, FORMULATION AND PHARMACEUTICAL APPLICATIONS THEREOF
TW200420573A (en)	2002-09-26	2004-10-16	Rib X Pharmaceuticals Inc	Bifunctional heterocyclic compounds and methods of making and using same
AU2004217919A1 (en) *	2003-03-05	2004-09-16	Rib-X Pharmaceuticals, Inc.	Bifunctional heterocyclic compounds and methods of making and using the same
HRP20030324A2 (en) *	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect
WO2005042554A1 (en) *	2003-10-30	2005-05-12	Rib-X Pharmaceuticals, Inc.	Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US20070270357A1 (en) *	2003-11-18	2007-11-22	Farmer Jay J	Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
EP1723159B1 (en)	2004-02-27	2019-06-12	Melinta Therapeutics, Inc.	Macrocyclic compounds and methods of making and using the same
US20060183696A1 (en) *	2004-08-12	2006-08-17	Pliva-Istrazivacki Institut D.O.O.	Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
KR20070046917A (ko) *	2004-08-12	2007-05-03	글락소스미쓰클라인 이스트라지바치키 센타 자그레브 디.오.오.	위장관의 염증성 질환의 치료를 위한 세포-특이적컨쥬게이트의 용도
ES2337915T3 (es)	2004-10-27	2010-04-30	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Conjugados con adtividad antiinflamatoria.
EP1844053A2 (en) *	2005-01-13	2007-10-17	GlaxoSmithKline istrazivacki centar Zagreb d.o.o.	Anti-inflammatory macrolide conjugates
RU2008106915A (ru) *	2005-07-26	2009-09-10	Меркле Гмбх (De)	Макролидные конъюгаты пирролиновых и индолизиновых соединений
WO2009006403A2 (en) *	2007-06-29	2009-01-08	Georgia Tech Research Corporation	Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
US8871728B2 (en)	2007-06-29	2014-10-28	Georgia Tech Research Corporation	Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
EP2625185A4 (en) *	2010-10-10	2014-03-26	Synovo Gmbh	INFLAMMATORY MAKROLIDE
JP5926484B2 (ja)	2010-11-18	2016-05-25	株式会社セルシード	グリコサミノグリカンの新規な分析方法
US10278925B2 (en)	2012-01-04	2019-05-07	Wellesley Pharmaceuticals, Llc	Delayed-release formulations, methods of making and use thereof
KR20190049928A (ko) *	2012-01-04	2019-05-09	웰즐리 파마슈티컬스 엘엘씨	배뇨 빈도를 감소시키기 위한 서방형 제제 및 이의 사용 방법
MY205435A (en)	2018-09-14	2024-10-21	Jiangyin Usun Pharmaceutical Co Ltd	New conjugates of montelukast and peptides
WO2023248010A2 (en) *	2022-06-23	2023-12-28	Synovo Gmbh	Targeted modulators of jak3 for treatment of inflammatory and autoimmune diseases

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB327084A (en) *	1928-10-19	1930-03-27	Ver Stahlwerke Ag	Improved method of and apparatus for introducing material to be rolled into rolling mills
US4474768A (en) *	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
HU198913B (en) *	1987-09-03	1989-12-28	Pliva Pharm & Chem Works	Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
LU87036A1 (fr) *	1987-11-04	1989-06-14	Oreal	Esters cycloaliphatiques insatures d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
US5466681A (en) *	1990-02-23	1995-11-14	Microcarb, Inc.	Receptor conjugates for targeting penicillin antibiotics to bacteria
US5965566A (en) *	1993-10-20	1999-10-12	Enzon, Inc.	High molecular weight polymer-based prodrugs
CA2252886C (en)	1996-04-26	2008-02-12	Massachusetts Institute Of Technology	Three-hybrid screening assay
HRP960497B1 (en) *	1996-10-28	2003-08-31	Pliva Pharm & Chem Works	9-n-ethenyl derivatives of 9(s)-erythromycylamine
GB2321455A (en) *	1997-01-24	1998-07-29	Norsk Hydro As	Lipophilic derivatives of biologically active compounds
HN1998000074A (es) *	1997-06-11	1999-01-08	Pfizer Prod Inc	Derivados de macrolidos c-4 sustituidos
GB2327084A (en) *	1997-07-08	1999-01-13	Merck & Co Inc	9a-Aza-3-ketolide antibiotics
EP0895999A1 (en) *	1997-08-06	1999-02-10	Pfizer Products Inc.	C-4" substituted macrolide antibiotics
WO1999028308A1 (en)	1997-11-29	1999-06-10	Truett William L	Antibiotics and process for preparation
WO1999064040A1 (en)	1998-06-08	1999-12-16	Advanced Medicine, Inc.	Novel polyene macrolide compounds and uses
US6288234B1 (en) *	1998-06-08	2001-09-11	Advanced Medicine, Inc.	Multibinding inhibitors of microsomal triglyceride transferase protein
US6043227A (en) *	1998-08-19	2000-03-28	Pfizer Inc.	C11 carbamates of macrolide antibacterials
IT1306205B1 (it) *	1999-01-15	2001-05-30	Zambon Spa	Macrolidi ad attivita' antiinfiammatoria.
EP1046394A3 (en)	1999-04-19	2001-10-10	ImaRx Pharmaceutical Corp.	Novel compositions useful for delivering compounds into a cell
GB9909229D0 (en)	1999-04-23	1999-06-16	Glaxo Group Ltd	Enantiomers of mercapto lactones and processes for their synthesis
AU2001286727A1 (en)	2000-08-24	2002-03-04	Coulter Pharmaceutical, Inc.	Prodrugs activated by plasmin and their use in cancer chemotherapy
HRP20010018A2 (en) *	2001-01-09	2002-12-31	Pliva D D	Novel anti-inflammatory compounds
US20040186063A1 (en) *	2002-02-15	2004-09-23	Hans-Jurgen Gutke	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
US7271154B2 (en) *	2002-02-15	2007-09-18	Merckle Gmbh	Antibiotic conjugates
AU2003219770B2 (en)	2002-02-15	2008-10-09	Merckle Gmbh	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1483579A4 (en) *	2002-02-15	2006-07-12	Merckle Gmbh	CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THEIR MANUFACTURE AND USE, FORMULATION AND PHARMACEUTICAL APPLICATIONS THEREOF

2003
- 2003-07-07 EP EP03762824A patent/EP1521763A2/en not_active Withdrawn
- 2003-07-07 CA CA002489398A patent/CA2489398A1/en not_active Abandoned
- 2003-07-07 AU AU2003255849A patent/AU2003255849A1/en not_active Abandoned
- 2003-07-07 JP JP2004519020A patent/JP2005536488A/ja active Pending
- 2003-07-07 CN CNB038160927A patent/CN100417659C/zh not_active Expired - Fee Related
- 2003-07-07 WO PCT/HR2003/000035 patent/WO2004005309A2/en not_active Ceased
- 2003-07-07 RU RU2005103227/04A patent/RU2342398C2/ru not_active IP Right Cessation
- 2003-07-07 RS YUP-2005/0007A patent/RS20050007A/sr unknown
- 2003-07-07 BR BR0312584-0A patent/BR0312584A/pt not_active IP Right Cessation
- 2003-07-07 US US10/615,010 patent/US7109176B2/en not_active Expired - Fee Related
- 2003-07-07 NZ NZ537716A patent/NZ537716A/en unknown
- 2003-07-07 PL PL03374646A patent/PL374646A1/xx not_active Application Discontinuation
- 2003-07-10 AR ARP030102489A patent/AR040951A1/es unknown
2005
- 2005-02-02 NO NO20050571A patent/NO20050571L/no not_active Application Discontinuation
- 2005-02-04 IS IS7686A patent/IS7686A/is unknown
2010
- 2010-09-21 JP JP2010211027A patent/JP2011006474A/ja not_active Ceased

Also Published As

Publication number	Publication date
EP1521763A2 (en)	2005-04-13
AR040951A1 (es)	2005-04-27
IS7686A (is)	2005-02-04
JP2011006474A (ja)	2011-01-13
JP2005536488A (ja)	2005-12-02
BR0312584A (pt)	2005-04-12
HK1080865A1 (en)	2006-05-04
US20040097434A1 (en)	2004-05-20
CA2489398A1 (en)	2004-01-15
CN1665829A (zh)	2005-09-07
RS20050007A (sr)	2007-09-21
NZ537716A (en)	2007-05-31
WO2004005309A3 (en)	2004-04-15
PL374646A1 (en)	2005-10-31
WO2004005309A2 (en)	2004-01-15
US7109176B2 (en)	2006-09-19
CN100417659C (zh)	2008-09-10
RU2342398C2 (ru)	2008-12-27
RU2005103227A (ru)	2005-07-20
AU2003255849A1 (en)	2004-01-23

Legal Events

Date	Code	Title	Description
2010-03-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20050571L (no)	2005-03-31	Nye ikke steroide anti-inflammatoriske substanser, sammensetninger og metoder for deres anvendelse
NO20073932L (no)	2007-08-09	Fuserte bicykliske karboksamidderivater for anvendelse som CXCR2 inhibitorer i behandlingen av inflammasjon
NO20072978L (no)	2007-06-27	Nye betuinderivater, preparat derav og anvendelse derav
NO20072605L (no)	2007-09-05	Nytt antranilinsyrederivat eller et salt derav
NO20085100L (no)	2009-01-07	Nye forbindelser
ATE540932T1 (de)	2012-01-15	Hydantoin-derivate als antibakterielle wirkstoffe
NO20084845L (no)	2009-02-03	2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig
NO20076195L (no)	2008-02-27	Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer
NO20081888L (no)	2008-07-01	Triazolforbindelser som lipoksygenaseinhibitorer
EP1508570A4 (en)	2007-08-15	NEW PHYSIOLOGICAL ACTIVE SUBSTANCES
NO20081804L (no)	2008-07-03	Pyrazolforbindelser egnet til behandling av inflammasjon
BR0311767A (pt)	2005-03-08	Compostos inibidores de sulfonamida substituìda da produção de beta amilóide, suas composições e usos
DE602005016297D1 (de)	2009-10-08	Antithrombotische diamide
NO20055535L (no)	2006-01-16	Makrodkonjugater med anti-inflammatorisk aktivitet
IL182694A0 (en)	2007-09-20	Conjugates with anti-inflammatory activity
NO20065880L (no)	2006-12-20	3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor
NO20070789L (no)	2007-03-21	Nikotinreseptoragonister for behandling av betennelsessykdommer
NO20052730L (no)	2005-08-23	Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
ATE495159T1 (de)	2011-01-15	Diaminocyclohexan- und diaminocyclopentanderivate
NO20071244L (no)	2007-04-17	Anvendelse av cellespesifikke konjugater for behandling av inflammasjonssykdommer i gastrointestinaltrakten
EA201001566A1 (ru)	2011-04-29	Новый класс спиропиперидинов для лечения нейродегенеративных заболеваний
NO20071754L (no)	2007-04-02	Biotinylerte heksadekasakkarider, fremstilling og anvendelse derav
ATE284882T1 (de)	2005-01-15	Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
EA200970779A1 (ru)	2010-04-30	Новое сульфированное соединение сахара и его применение в качестве лекарственного средства
ATE382607T1 (de)	2008-01-15	Antitrombotische aether